547 related articles for article (PubMed ID: 12868123)
21. Prevention and treatment of osteoporosis in women with breast cancer.
Mincey BA; Moraghan TJ; Perez EA
Mayo Clin Proc; 2000 Aug; 75(8):821-9. PubMed ID: 10943237
[TBL] [Abstract][Full Text] [Related]
22. Preventing and treating osteoporosis: strategies at the millennium.
Sherman S
Ann N Y Acad Sci; 2001 Dec; 949():188-97. PubMed ID: 11795353
[TBL] [Abstract][Full Text] [Related]
23. Preventing osteoporosis in symptomatic postmenopausal women.
Gallagher JC; Levine JP
Menopause; 2011 Jan; 18(1):109-18. PubMed ID: 20661164
[TBL] [Abstract][Full Text] [Related]
24. Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study.
Muscoso E; Puglisi N; Mamazza C; Lo Giudice F; Testai M; Abbate S; Santangelo A; Panebianco P; Maugeri D
Eur Rev Med Pharmacol Sci; 2004; 8(2):97-102. PubMed ID: 15267123
[TBL] [Abstract][Full Text] [Related]
25. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2006; 13(3):340-67; quiz 368-9. PubMed ID: 16735931
[TBL] [Abstract][Full Text] [Related]
26. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis and management of primary osteoporosis.
Bauwens SF; Drinka PJ; Boh LE
Clin Pharm; 1986 Aug; 5(8):639-59. PubMed ID: 3527528
[TBL] [Abstract][Full Text] [Related]
28. [Role of estrogen and selective estrogen receptor modulators in anti-aging].
Ohta H
Clin Calcium; 2008 Jul; 18(7):986-94. PubMed ID: 18591752
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
30. Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.
Ebeling PR; Russell RG
Int J Clin Pract; 2003 Oct; 57(8):710-8. PubMed ID: 14627183
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic options in osteoporosis.
Dominguez LJ; Scalisi R; Barbagallo M
Acta Biomed; 2010; 81 Suppl 1():55-65. PubMed ID: 20518192
[TBL] [Abstract][Full Text] [Related]
32. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
[TBL] [Abstract][Full Text] [Related]
33. [Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy].
Burckhardt P
Schweiz Med Wochenschr; 1999 Dec; 129(49):1926-30. PubMed ID: 10635085
[TBL] [Abstract][Full Text] [Related]
34. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
Brixen KT; Christensen PM; Ejersted C; Langdahl BL
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
[TBL] [Abstract][Full Text] [Related]
35. Prevention of osteoporotic fractures in post-menopausal women.
Compston J
Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Jun; 14(2):251-64. PubMed ID: 11035905
[TBL] [Abstract][Full Text] [Related]
36. Management of postmenopausal osteoporosis: position statement of the North American Menopause Society.
North American Menopause Society.
Menopause; 2002; 9(2):84-101. PubMed ID: 11875327
[TBL] [Abstract][Full Text] [Related]
37. Therapies to improve bone mineral density and reduce the risk of fracture: clinical trial results.
Watts NB
J Reprod Med; 2002 Jan; 47(1 Suppl):82-92. PubMed ID: 11829081
[TBL] [Abstract][Full Text] [Related]
38. Evidence-based medicine and osteoporosis: a comparison of fracture risk reduction data from osteoporosis randomised clinical trials.
Meunier PJ
Int J Clin Pract; 1999 Mar; 53(2):122-9. PubMed ID: 10344048
[TBL] [Abstract][Full Text] [Related]
39. [Prevention of osteoporotic fracture by pharmaceutical interventions].
Nakamura T
Clin Calcium; 2006 Dec; 16(12):1961-67. PubMed ID: 17142925
[TBL] [Abstract][Full Text] [Related]
40. Osteoporosis: a review and its dental implications.
Mattson JS; Cerutis DR; Parrish LC
Compend Contin Educ Dent; 2002 Nov; 23(11):1001-4, 1006, 1008 passim; quiz 1014. PubMed ID: 12526189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]